TRP — Tissue Repair Income Statement
0.000.00%
- AU$19.65m
- AU$7.33m
- AU$3.02m
- 50
- 37
- 86
- 62
Annual income statement for Tissue Repair, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.003 | 0.896 | 3.02 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.706 | 5.45 | 5.74 | 6.67 | 7.46 |
| Operating Profit | -0.706 | -5.45 | -5.74 | -5.77 | -4.44 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.915 | -6.84 | -4.17 | -4.14 | -4.24 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.915 | -6.84 | -4.17 | -4.14 | -4.24 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.915 | -6.84 | -4.17 | -4.14 | -4.24 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.915 | -6.84 | -4.17 | -4.14 | -4.24 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.014 | -0.113 | -0.069 | -0.068 | -0.07 |